Stockscreener 앱 받기
164.46
0.46%
0.755
전일 마감가:
$163.70
열려 있는:
$163.77
하루 거래량:
3.65M
Relative Volume:
0.45
시가총액:
$395.73B
수익:
$90.63B
순이익/손실:
$22.66B
주가수익비율:
17.59
EPS:
9.35
순현금흐름:
$18.57B
1주 성능:
+4.86%
1개월 성능:
+9.78%
6개월 성능:
+11.00%
1년 성능:
+6.31%
1일 변동 폭
$162.78
$164.91
1주일 범위
$154.80
$166.12
52주 변동 폭
$140.68
$169.90
존슨앤존슨 Stock (JNJ) Company Profile
명칭
Johnson Johnson
전화
732-524-2455
주소
ONE JOHNSON & JOHNSON PLZ, NEW BRUNSWICK, NJ
JNJ을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
JNJ
Johnson Johnson
|
164.47 | 377.32B | 90.63B | 22.66B | 18.57B | 9.35 |
|
LLY
Lilly Eli Co
|
765.07 | 717.60B | 49.00B | 11.11B | -1.27B | 12.29 |
|
ABBV
Abbvie Inc
|
186.11 | 338.30B | 57.37B | 4.20B | 15.39B | 2.35 |
|
NVS
Novartis Ag Adr
|
114.55 | 234.32B | 55.19B | 13.65B | 16.81B | 6.86 |
|
NVO
Novo Nordisk Adr
|
64.94 | 306.33B | 43.59B | 15.04B | 10.74B | 3.3766 |
존슨앤존슨 Stock (JNJ) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-05-13 | 다운그레이드 | Leerink Partners | Outperform → Market Perform |
| 2024-12-10 | 재개 | BofA Securities | Neutral |
| 2024-11-15 | 개시 | Wolfe Research | Outperform |
| 2024-07-23 | 다운그레이드 | Daiwa Securities | Outperform → Neutral |
| 2024-05-30 | 재개 | Goldman | Neutral |
| 2024-04-18 | 업그레이드 | HSBC Securities | Hold → Buy |
| 2023-12-13 | 다운그레이드 | Wells Fargo | Overweight → Equal Weight |
| 2023-12-01 | 업그레이드 | UBS | Neutral → Buy |
| 2023-10-05 | 개시 | RBC Capital Mkts | Outperform |
| 2023-09-06 | 개시 | HSBC Securities | Hold |
| 2023-05-30 | 재개 | Citigroup | Buy |
| 2023-03-29 | 개시 | UBS | Neutral |
| 2023-03-01 | 개시 | Guggenheim | Neutral |
| 2022-11-18 | 개시 | Credit Suisse | Neutral |
| 2022-10-18 | 개시 | Barclays | Equal Weight |
| 2022-10-14 | 재확인 | BofA Securities | Neutral |
| 2022-06-22 | 개시 | Daiwa Securities | Outperform |
| 2022-05-23 | 재개 | SVB Leerink | Outperform |
| 2022-04-06 | 재개 | Morgan Stanley | Equal-Weight |
| 2022-03-16 | 다운그레이드 | Bernstein | Outperform → Mkt Perform |
| 2022-03-02 | 재개 | BofA Securities | Neutral |
| 2021-12-17 | 개시 | Goldman | Neutral |
| 2021-12-15 | 재확인 | Citigroup | Buy |
| 2021-09-07 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2021-05-28 | 재개 | Morgan Stanley | Overweight |
| 2020-04-28 | 다운그레이드 | UBS | Buy → Neutral |
| 2020-04-22 | 업그레이드 | BofA/Merrill | Neutral → Buy |
| 2020-03-05 | 개시 | Citigroup | Buy |
| 2019-12-19 | 업그레이드 | Barclays | Equal Weight → Overweight |
| 2019-12-17 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
| 2019-11-20 | 개시 | Cantor Fitzgerald | Overweight |
| 2019-10-16 | 업그레이드 | Atlantic Equities | Underweight → Neutral |
| 2019-10-11 | 업그레이드 | Bernstein | Mkt Perform → Outperform |
| 2019-07-12 | 재개 | Credit Suisse | Outperform |
| 2019-05-28 | 개시 | Goldman | Buy |
| 2019-01-23 | 재확인 | Barclays | Equal Weight |
| 2018-07-12 | 업그레이드 | Goldman | Sell → Neutral |
| 2018-06-27 | 개시 | Bernstein | Mkt Perform |
| 2018-04-23 | 재확인 | Citigroup | Neutral |
| 2018-04-18 | 재확인 | Stifel | Hold |
| 2018-01-24 | 재확인 | Stifel | Hold |
| 2018-01-12 | 재확인 | Wells Fargo | Outperform |
| 2018-01-02 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2017-10-18 | 재확인 | RBC Capital Mkts | Outperform |
| 2017-10-18 | 재확인 | Stifel | Hold |
모두보기
존슨앤존슨 주식(JNJ)의 최신 뉴스
J&J submits icotrokinra NDA for plaque psoriasis in patients 12 years and up - Contemporary Pediatrics
Master Watershed Steward Rose Johnson brings a green thumb to Philadelphia - Penn State University
Johnson & Johnson (JNJ): I Counted 15 Separate Surprises,” Says Jim Cramer - Yahoo.co
What Bees Can Teach Us About Survival and Well-being - Civil Eats
Film room: Freshman Anna Wikstrom immediately bolsters Duke's scoring and guard depth - dukechronicle.com
The biggest red flag in a job interview, according to a founder—and what impresses her most - CNBC
Trade Alert: Executive Vice President of Innovative Medicine Of Johnson & Johnson John Reed Has Sold Stock - simplywall.st
10 Magnificent S&P 500 Dividend Stocks Down Over 10% to Buy and Hold Forever - The Motley Fool
Jets Place Jermaine Johnson and Irv Charles on Active/PUP - New York Jets
Jaylon Johnson and three others on active non-football injury list - Sports Illustrated
Outdoor Indigenous museum in Yukon celebrates 30 years - CBC
NFL news roundup: Bears place CB Jaylon Johnson on NFI list; Saints sign DE Jonathan Bullard - NFL.com
Obituary | Sheila Jean Johnson of Glidden, Iowa - dahnandwoodhouse.com
Johnson & Johnson’s (JNJ) Dividend Track Record: Reliability in Uncertain Times - Yahoo Finance
Johnson & Johnson - Britannica
Jimmy Johnson gives his "No. 1 key" for Schotty & Cowboys in 2025 - Dallas Cowboys
J&J Talc Creditor Firms Decry Judge’s Failure to Address Fees - Bloomberg Law News
Emory research team helps uncover early Alzheimer’s risk markers in adults with Down syndrome - Emory News Center
Breakdown of Bengals 2025 Player Personnel Staff Shows Experience and Versatility - Cincinnati Bengals
Johnson & Johnson price target raised to $167 from $164 at Guggenheim - Yahoo Finance
2025 NBA summer league superlatives: Promising rookies, impactful veterans - ESPN
Johnson & Johnson’s TAR-200 granted FDA priority review to treat bladder cancer - PMLiVE
How bipartisan support for public media unraveled in the Trump era - NPR
Guggenheim Maintained a Hold Rating on Johnson & Johnson (JNJ) - Yahoo Finance
Current Epidemic Trends (Based on Rt) for States | CFA: Modeling and Forecasting - Centers for Disease Control and Prevention | CDC (.gov)
Moesha Johnson holds off Taddeucci once more in the 5km - World Aquatics
Congress rolls back $9 billion in public media funding and foreign aid - NPR
Scoop: House Democrats shrug off delay tactics to stall Mike Johnson's DOGE vote - Axios
Republicans plot endgame on rescissions package — and Epstein files - Politico
Moesha Johnson wins back-to-back world titles after thrilling sprint - Australian Broadcasting Corporation
House GOP closes in on Epstein measure amid rebellion - Politico
Jim Cramer explains why Johnson & Johnson rallied after 'surprise' earnings results - CNBC
Watch These Johnson & Johnson Price Levels After Stock's Post-Earnings Pop - Investopedia
Crypto bills advance after record stalemate in GOP HouseABC News - ABC News - Breaking News, Latest News and Videos
Former HSBC trader has fraud conviction overturned - BBC
Looming Epstein vote has Republicans eager to leave Washington - Politico
40-year-old sold her company for $22 million—2 years later she bought it back and is launching a 'Coachella for career women' - CNBC
Johnson & Johnson receives U.S. FDA Priority Review for TAR-200 NDA in high-risk non-muscle invasive bladder cancer - Johnson & Johnson
NASA Program Builds Bridge From Military to Civilian Careers for Johnson Team Members - NASA (.gov)
Brutal day ahead for Johnson - Politico
Obituary for John K. Larson at Johnson Funeral Home - Johnson Funeral Home Waconia, MN
City Council upholds Mayor Brandon Johnson's veto of "snap curfew" ordinance - CBS News
Bussiere, Bratton Tapped For Air Force and Space Force Vice Chief Roles - Air & Space Forces Magazine
Johnson & Johnson Earnings: Surpassing Expectations Across the Board - Morningstar
S&P 500 Gains and Losses Today: Johnson & Johnson Stock Jumps; Universal Health Services Shares Slide - Investopedia
Stock Movers: Johnson & Johnson, Ford, United Airlines - Bloomberg
Johnson & Johnson executive predicts Tremfya will be a '$10 billion dollar drug' - Fox Business
Dow Jones Health Giant Surges On Hiked Guidance - Investor's Business Daily
Johnson & Johnson (JNJ) Q2 Earnings and Revenues Top Estimates - Yahoo Finance
Robert Wood Johnson University Hospital Awarded Third Consecutive Disease-Specific Care Re-Certification for Spine Surgery from - RWJBarnabas Health
Final Trades: Johnson & Johnson, ICE and the IBIT - CNBC
존슨앤존슨 (JNJ) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.06%
자본화:
|
볼륨(24시간):